pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
AMICUS THERAPEUTICS, INC. ($FOLD) · news · pharmadog
← back to AMICUS THERAPEUTICS, INC.
News mentioning $FOLD
55
stories
Sep 8, 26
An administrative gap delays access to new pancreatic cancer treatment
stat
Sep 4, 26
Pfizer punts Seagen ADC, further muddying value of the $43B buyout
biospace
Sep 3, 26
STAT+: Seattle scientists launch $95 million AI biology effort
stat
Sep 3, 26
GSK inks another Asia alliance, betting up to $1.3B for HUTCHMED’s cancer therapy
biospace
Aug 27, 26
Myriad catalysts on deck for obesity’s brightest stars as market continues to accelerate
biospace
Aug 26, 26
Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA
biopharma dive
Aug 25, 26
McKesson strikes $2.25B deal to snap up Precision Medicine Group
fiercebiotech
Aug 21, 26
Novo Nordisk starts trialing lower maintenance doses of oral Wegovy
biospace
Aug 20, 26
7 biopharma M&A deals where layoffs followed
biospace
Aug 19, 26
Novo takes first round of oral obesity duel. Can it stay ahead of Lilly?
biospace
Aug 12, 26
AI clinical monitoring agent can deliver up to 82 times the ROI in oncology: report
fiercebiotech
Aug 11, 26
After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’
fiercebiotech
Aug 4, 26
The China Debate: Biotech deserves a deeper discussion
endpoints
Jul 29, 26
‘We have what we need to grow:’ Biogen CEO happy to ease off the M&A for a while
fiercebiotech
Jul 27, 26
FDA approves Freenome colorectal cancer blood test to be marketed by Abbott
fiercebiotech
Jul 18, 26
Opinion: STAT readers on the value of primary care, obesity as a disease, and more
stat
Jul 17, 26
India’s life sciences sector at turning point for innovation: Report
biospace
Jul 15, 26
Nobel Laureate Jennifer Doudna enters AI protein design arena
fiercebiotech
May 31, 26
‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer
biopharma dive
May 19, 26
BioMarin drug acquired in buyout misses goal in rare disease study
biopharma dive
May 13, 26
Abeona pivots to T cells; AstraZeneca's rare disease drug passes Phase 3
endpoints
May 8, 26
Odyssey, on second try, snags $279M in an IPO
biopharma dive
May 7, 26
Sylvester Comprehensive Cancer Center Identifies a Screening Gap to Prevent a Type of Leukemia in the U.S.
onclive
May 4, 26
Federal court blocks mailing of mifepristone
stat
Apr 27, 26
Veradermics soars on positive data for baldness treatment
biopharma dive
← prev
page 2 of 2
next →